Acadian Asset Management LLC Talaris Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
SELL
$1.78 - $3.2 $404,590 - $727,353
-227,298 Reduced 95.3%
11,215 $34,000
Q1 2023

May 11, 2023
BUY
$1.09 - $2.09 $138,542 - $265,645
127,103 Added 114.09%
238,513 $447,000
Q4 2022

Feb 14, 2023
BUY
$0.94 - $1.64 $66,516 - $116,049
70,762 Added 174.08%
111,410 $113,000
Q3 2022

Nov 14, 2022
BUY
$2.3 - $5.03 $93,490 - $204,459
40,648 New
40,648 $106,000

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email